- A single injection of nirsevimab administered before the RSV season protected healthy late-preterm and term infants from medically attended RSV-associated lower respiratory tract infection. https://www.nejm.org/doi/full/10.1056/NEJMoa2110275 5 comments science
Linking pages
- Protecting Babies Against RSV Is Still Too Hard - The Atlantic https://www.theatlantic.com/health/archive/2024/03/cdc-rsv-vaccine-babies-eligible/677907/ 2 comments
- For decades, fear and failure in the hunt for an RSV vaccine. Now, success. - The Washington Post https://www.washingtonpost.com/health/2022/10/10/rsv-vaccine/ 0 comments
- RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies https://theconversation.com/rsv-treatments-for-young-children-are-lacking-but-the-record-2022-cold-and-flu-season-highlights-the-urgency-for-vaccines-and-other-preventive-strategies-195700 0 comments
- FDA approves antibody to protect infants from RSV | CNN https://www.cnn.com/2023/07/17/health/rsv-antibody-nirsevimab/index.html 0 comments
Linked pages
Related searches:
Search whole site: site:www.nejm.org
Search title: Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants | NEJM
See how to search.